Dr Dominick Trinca, MD | |
702 Martin Luther King St, Mound Bayou, MS 38762-9314 | |
(662) 741-8800 | |
(662) 741-2700 |
Full Name | Dr Dominick Trinca |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 702 Martin Luther King St, Mound Bayou, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285886465 | NPI | - | NPPES |
1053550236 | Other | MS | MEDICARE NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 14017 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Dominick Trinca, MD 702 Martin Luther King St, Mound Bayou, MS 38762-9314 Ph: (662) 741-8800 | Dr Dominick Trinca, MD 702 Martin Luther King St, Mound Bayou, MS 38762-9314 Ph: (662) 741-8800 |
News Archive
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level.
Finding a drug that targets only the diseased cells in our body and is otherwise harmless to healthy tissue is a goal for cancer researchers. It's driven the work of Professor Laurence Patterson, Director of the Institute of Cancer Therapeutics at the University of Bradford, and his team of researchers.
A U.S. senator, an Army leader and a military surgeon are among the "Heroes of Military Medicine" to be honored May 4 by the Henry M. Jackson Foundation for the Advancement of Military Medicine's Center for Public-Private Partnerships.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trials were presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS).
› Verified 6 days ago